CLINICAL STUDY: DIABETES AND CARDIOVASCULAR DISEASE
Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes
Marcelo F. Di Carli, MD*,*  ,
James Janisse, PhD ,
George Grunberger, MD* and
Joel Ager, PhD
* Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA
Department of Radiology, Wayne State University School of Medicine, Detroit, Michigan, USA
Center for Healthcare Effectiveness Research, Wayne State University School of Medicine, Detroit, Michigan, USA
Positron Emission Tomography Center , Children’s Hospital of Michigan, Detroit, Michigan, USA
Manuscript received July 3, 2002;
revised manuscript received October 3, 2002,
accepted November 27, 2002.
* Reprint requests and correspondence: Dr. Marcelo F. Di Carli, Brigham and Women’s Hospital, Division of Nuclear Medicine, 75 Francis Street, Boston, Massachusetts, USA 02115.
mdicarli{at}bics.bwh.harvard.edu
OBJECTIVES: We sought to determine the differences in coronary microvascular function between patients with type 1 (insulin-deficient) and type 2 (insulin-resistant) diabetes mellitus (DM).
BACKGROUND: Coronary vascular function is impaired in patients with DM. However, it is unclear whether the type and/or severity of this vascular dysfunction are similar in patients with type 1 and type 2 DM.
METHODS: We studied 35 young subjects with DM (18 with type 1 and 17 with type 2), who were free of overt cardiovascular complications, and 11 age-matched healthy controls. Positron emission tomography imaging was used to measure myocardial blood flow (MBF) at rest, during adenosine-induced hyperemia (reflecting primarily endothelium-independent vasodilation), and in response to cold pressor test (CPT) (reflecting primarily endothelium-dependent vasodilation).
RESULTS: The two groups of diabetics were similar with respect to age and glycemic control. The duration of diabetes was longer and high-density lipoprotein cholesterol levels were higher in type 1 than in type 2 diabetics. Basal MBF was similar in the three groups studied. The increase (from baseline) in MBF with adenosine was similar in the subjects with type 1 (161 ± 18%) and type 2 (185 ± 19%) DM, but lower than in the controls (351 ± 43%) (p < 0.001 for the comparison with both groups of diabetics). Similarly, the increase in MBF during the CPT was comparable in the subjects with type 1 (23 ± 4%) and type 2 (19 ± 3%) DM, but lower compared with the controls (66 ± 12%) (p < 0.0001 for the comparison with both groups of diabetics). These differences persisted after adjusting for the duration of diabetes, insulin treatment, metabolic abnormalities, and autonomic neuropathy.
CONCLUSIONS: These results demonstrate markedly reduced and similar endothelium-dependent and -independent coronary vasodilator function in subjects with both type 1 and type 2 DM. These results suggest a key role of chronic hyperglycemia in the pathogenesis of vascular dysfunction in diabetes.
|
Abbreviations and Acronyms
| | ANOVA | | analysis of variance | | BMI | | body mass index | | BP | | blood pressure | | CAD | | coronary artery disease | | CPT | | cold pressor test | | DM | | diabetes mellitus | | ECG | | electrocardiogram | | HDL | | high-density lipoprotein | | HED | | [11C]hydroxyephedrine | | MBF | | myocardial blood flow | | PET | | positron emission tomography | | ROI | | regions of interest | | vWF | | von Willebrand factor |
|
This article has been cited by other articles:
|
|
|
|
 
T. Hayashi, Y. Obi, T. Kimura, K.-i. Iio, S. Sumitsuji, Y. Takeda, Y. Nagai, and E. Imai
Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy
Nephrol. Dial. Transplant.,
September 1, 2008;
23(9):
2936 - 2942.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Gebker, C. Jahnke, R. Manka, A. Hamdan, B. Schnackenburg, E. Fleck, and I. Paetsch
Additional Value of Myocardial Perfusion Imaging During Dobutamine Stress Magnetic Resonance for the Assessment of Coronary Artery Disease
Circ Cardiovasc Imaging,
September 1, 2008;
1(2):
122 - 130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Cheung, J. J. Wang, S. L. Rogers, F. Brancati, R. Klein, A. R. Sharrett, T. Y. Wong, and for the ARIC (Atherosclerosis Risk In Communities)
Diabetic retinopathy and risk of heart failure.
J. Am. Coll. Cardiol.,
April 22, 2008;
51(16):
1573 - 1578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Cortigiani, F. Rigo, S. Gherardi, R. Sicari, M. Galderisi, F. Bovenzi, and E. Picano
Additional Prognostic Value of Coronary Flow Reserve in Diabetic and Nondiabetic Patients With Negative Dipyridamole Stress Echocardiography by Wall Motion Criteria
J. Am. Coll. Cardiol.,
October 2, 2007;
50(14):
1354 - 1361.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Cheung, J. J. Wang, R. Klein, D. J. Couper, A. R. Sharrett, and T. Y. Wong
Diabetic Retinopathy and the Risk of Coronary Heart Disease: The Atherosclerosis Risk in Communities Study
Diabetes Care,
July 1, 2007;
30(7):
1742 - 1746.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Camici and F. Crea
Coronary Microvascular Dysfunction
N. Engl. J. Med.,
February 22, 2007;
356(8):
830 - 840.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Madsen, H. M. Sondergaard, M. Bottcher, N. H. Buus, O. Schmitz, H. E. Botker, and T. T. Nielsen
Impact of Type 2 Diabetes on Nitric Oxide and Adrenergic Modulation of Myocardial Perfusion
Diabetes,
February 1, 2007;
56(2):
468 - 475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Henneman, J. D. Schuijf, E. E. van der Wall, and J. J. Bax
Non-invasive anatomical and functional imaging for the detection of coronary artery disease
Br. Med. Bull.,
January 5, 2007;
(2007)
ldl014v2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Facchiano, D. D'Arcangelo, K. Russo, V. Fogliano, C. Mennella, R. Ragone, G. Zambruno, V. Carbone, D. Ribatti, C. Peschle, et al.
Glycated Fibroblast Growth Factor-2 Is Quickly Produced in Vitro upon Low-Millimolar Glucose Treatment and Detected in Vivo in Diabetic Mice
Mol. Endocrinol.,
November 1, 2006;
20(11):
2806 - 2818.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T. Siegrist, O. Gaemperli, P. Koepfli, T. Schepis, M. Namdar, I. Valenta, F. Aiello, S. Fleischmann, H. Alkadhi, and P. A. Kaufmann
Repeatability of Cold Pressor Test-Induced Flow Increase Assessed with H215O and PET
J. Nucl. Med.,
September 1, 2006;
47(9):
1420 - 1426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Madar, H. T. Ravert, Y. Du, J. Hilton, L. Volokh, R. F. Dannals, J. J. Frost, and J. M. Hare
Characterization of Uptake of the New PET Imaging Compound 18F-Fluorobenzyl Triphenyl Phosphonium in Dog Myocardium
J. Nucl. Med.,
August 1, 2006;
47(8):
1359 - 1366.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z Kadri, N Danchin, L Vaur, Y Cottin, P Gueret, M Zeller, J-M Lablanche, D Blanchard, G Hanania, N Genes, et al.
Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study
Heart,
July 1, 2006;
92(7):
910 - 915.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H. Schindler, J. Cardenas, J. O. Prior, A. D. Facta, M. C. Kreissl, X.-L. Zhang, J. Sayre, M. Dahlbom, J. Licinio, and H. R. Schelbert
Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function
J. Am. Coll. Cardiol.,
March 21, 2006;
47(6):
1188 - 1195.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wang, M. Jerosch-Herold, D. R. Jacobs Jr, E. Shahar, and A. R. Folsom
Coronary Risk Factors and Myocardial Perfusion in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA)
J. Am. Coll. Cardiol.,
February 7, 2006;
47(3):
565 - 572.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. N. Bairey Merz, L. J. Shaw, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, C. J. Pepine, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease
J. Am. Coll. Cardiol.,
February 7, 2006;
47(3_Suppl_S):
S21 - S29.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. E. Vicario, L. Cirillo, G. Storto, T. Pellegrino, N. Ragone, L. Fontanella, M. Petretta, D. Bonaduce, and A. Cuocolo
Influence of Risk Factors on Coronary Flow Reserve in Patients with 1-Vessel Coronary Artery Disease
J. Nucl. Med.,
September 1, 2005;
46(9):
1438 - 1443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Srinivasan, P. Herrero, J. B. McGill, J. Bennik, B. Heere, D. Lesniak, V. G. Davila-Roman, and R. J. Gropler
The Effects of Plasma Insulin and Glucose on Myocardial Blood Flow in Patients With Type 1 Diabetes Mellitus
J. Am. Coll. Cardiol.,
July 5, 2005;
46(1):
42 - 48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Taegtmeyer
Glucose for the Heart: Too Much of a Good Thing?
J. Am. Coll. Cardiol.,
July 5, 2005;
46(1):
49 - 50.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. T. McMahon, J. Plutzky, E. Daher, T. Bhattacharyya, G. Grunberger, and M. F. DiCarli
Effect of a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist on Myocardial Blood Flow in Type 2 Diabetes
Diabetes Care,
May 1, 2005;
28(5):
1145 - 1150.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. Di Carli and R. Hachamovitch
Should we screen for occult coronary artery disease among asymptomatic patients with diabetes?
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
50 - 53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Kaufmann and P. G. Camici
Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications
J. Nucl. Med.,
January 1, 2005;
46(1):
75 - 88.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens
Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction
J. Am. Coll. Cardiol.,
December 21, 2004;
44(12):
2368 - 2374.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. J. French and R. S. Wright
Renal insufficiency and worsened prognosis with STEMI: A call for action
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1544 - 1546.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Herzog
How to Manage the Renal Patient with Coronary Heart Disease: The Agony and the Ecstasy of Opinion-Based Medicine
J. Am. Soc. Nephrol.,
October 1, 2003;
14(10):
2556 - 2572.
[Full Text]
[PDF]
|
|
|
|
